Trends in the availability and prices of quality-assured tuberculosis drugs: a systematic analysis of Global Drug Facility Product Catalogs from 2001 to 2024
Abstract Background The Global Drug Facility (GDF) of the Stop TB Partnership was launched in 2001 with the goal of increasing access to quality-assured tuberculosis (TB) drugs and products. We aimed to describe the TB drugs and prices available from the GDF over time and to assess trends. Methods W...
Saved in:
Main Authors: | Stefan Kohler (Author), Jay Achar (Author), Christiaan Mulder (Author), Norman Sitali (Author), Nicolas Paul (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan
by: Stefan Kohler, et al.
Published: (2022) -
The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan.
by: Stefan Kohler, et al.
Published: (2022) -
Correction: The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan.
by: Stefan Kohler, et al.
Published: (2024) -
Two years post affordable medicines facility for malaria program: availability and prices of anti-malarial drugs in central Ghana
by: Alexander Freeman, et al.
Published: (2017) -
Has the increase in the availability of generic drugs lowered the price of cardiovascular drugs in South Africa?
by: Varsha Bangalee, et al.
Published: (2016)